Hafner L, Gadin E, Huang L, Frouin A, Laporte F, Gaultier C
Nat Microbiol. 2024; 9(12):3345-3361.
PMID: 39578578
DOI: 10.1038/s41564-024-01859-8.
Sugawara-Mikami M, Tanigawa K, Kawashima A, Kiriya M, Nakamura Y, Fujiwara Y
Virulence. 2022; 13(1):1985-2011.
PMID: 36326715
PMC: 9635560.
DOI: 10.1080/21505594.2022.2141987.
Ha R, Keynan Y, Rueda Z
Front Cell Infect Microbiol. 2022; 12:980868.
PMID: 36159650
PMC: 9489861.
DOI: 10.3389/fcimb.2022.980868.
Kumar S, Mollo A, Kahne D, Ruiz N
Chem Rev. 2022; 122(9):8884-8910.
PMID: 35274942
PMC: 9098691.
DOI: 10.1021/acs.chemrev.1c00773.
Lee M, Hsieh K, Kuo C, Lee S, Garde S, Reddy M
mBio. 2022; 13(1):e0364621.
PMID: 35164571
PMC: 8844914.
DOI: 10.1128/mbio.03646-21.
Revisiting Anti-tuberculosis Therapeutic Strategies That Target the Peptidoglycan Structure and Synthesis.
Catalao M, Filipe S, Pimentel M
Front Microbiol. 2019; 10:190.
PMID: 30804921
PMC: 6378297.
DOI: 10.3389/fmicb.2019.00190.
Antimycobacterial drug discovery using Mycobacteria-infected amoebae identifies anti-infectives and new molecular targets.
Trofimov V, Kicka S, Mucaria S, Hanna N, Ramon-Olayo F, Vela-Gonzalez Del Peral L
Sci Rep. 2018; 8(1):3939.
PMID: 29500372
PMC: 5834492.
DOI: 10.1038/s41598-018-22228-6.
Mycobacterial cell wall biosynthesis: a multifaceted antibiotic target.
Abrahams K, Besra G
Parasitology. 2016; 145(2):116-133.
PMID: 27976597
PMC: 5964476.
DOI: 10.1017/S0031182016002377.
Development of a one-pot assay for screening and identification of Mur pathway inhibitors in Mycobacterium tuberculosis.
Eniyan K, Kumar A, Rayasam G, Perdih A, Bajpai U
Sci Rep. 2016; 6:35134.
PMID: 27734910
PMC: 5062083.
DOI: 10.1038/srep35134.
Lcp1 Is a Phosphotransferase Responsible for Ligating Arabinogalactan to Peptidoglycan in Mycobacterium tuberculosis.
Harrison J, Lloyd G, Joe M, Lowary T, Reynolds E, Walters-Morgan H
mBio. 2016; 7(4).
PMID: 27486192
PMC: 4981717.
DOI: 10.1128/mBio.00972-16.
Human NOD2 Recognizes Structurally Unique Muramyl Dipeptides from Mycobacterium leprae.
Schenk M, Mahapatra S, Le P, Kim H, Choi A, Brennan P
Infect Immun. 2016; 84(9):2429-38.
PMID: 27297389
PMC: 4995902.
DOI: 10.1128/IAI.00334-16.
Structural characterization of muropeptides from Chlamydia trachomatis peptidoglycan by mass spectrometry resolves "chlamydial anomaly".
Packiam M, Weinrick B, Jacobs Jr W, Maurelli A
Proc Natl Acad Sci U S A. 2015; 112(37):11660-5.
PMID: 26290580
PMC: 4577195.
DOI: 10.1073/pnas.1514026112.
The Mycobacterial Cell Wall--Peptidoglycan and Arabinogalactan.
Alderwick L, Harrison J, Lloyd G, Birch H
Cold Spring Harb Perspect Med. 2015; 5(8):a021113.
PMID: 25818664
PMC: 4526729.
DOI: 10.1101/cshperspect.a021113.
Structural and functional features of enzymes of Mycobacterium tuberculosis peptidoglycan biosynthesis as targets for drug development.
Moraes G, Cardoso Gomes G, de Sousa P, Alves C, Govender T, Kruger H
Tuberculosis (Edinb). 2015; 95(2):95-111.
PMID: 25701501
PMC: 4659487.
DOI: 10.1016/j.tube.2015.01.006.
Mycobacterium tuberculosis Rv1096 protein: gene cloning, protein expression, and peptidoglycan deacetylase activity.
Yang S, Zhang F, Kang J, Zhang W, Deng G, Xin Y
BMC Microbiol. 2014; 14:174.
PMID: 24975018
PMC: 4087242.
DOI: 10.1186/1471-2180-14-174.
Biosynthesis of a water-soluble lipid I analogue and a convenient assay for translocase I.
Siricilla S, Mitachi K, Skorupinska-Tudek K, Swiezewska E, Kurosu M
Anal Biochem. 2014; 461:36-45.
PMID: 24939461
PMC: 4296562.
DOI: 10.1016/j.ab.2014.05.018.
Characterisation of ATP-dependent Mur ligases involved in the biogenesis of cell wall peptidoglycan in Mycobacterium tuberculosis.
Munshi T, Gupta A, Evangelopoulos D, Guzman J, Gibbons S, Keep N
PLoS One. 2013; 8(3):e60143.
PMID: 23555903
PMC: 3605390.
DOI: 10.1371/journal.pone.0060143.
Defining mycobacteria: Shared and specific genome features for different lifestyles.
Vissa V, Sakamuri R, Li W, Brennan P
Indian J Microbiol. 2012; 49(1):11-47.
PMID: 23100749
PMC: 3450044.
DOI: 10.1007/s12088-009-0006-0.
Homology modeling and docking analyses of M. leprae Mur ligases reveals the common binding residues for structure based drug designing to eradicate leprosy.
Shanmugam A, Natarajan J
J Mol Model. 2011; 18(6):2659-72.
PMID: 22102165
DOI: 10.1007/s00894-011-1285-z.
Comparative modeling of UDP-N-acetylmuramoyl-glycyl-D-glutamate-2, 6-diaminopimelate ligase from Mycobacterium leprae and analysis of its binding features through molecular docking studies.
Shanmugam A, Natarajan J
J Mol Model. 2011; 18(1):115-25.
PMID: 21491188
DOI: 10.1007/s00894-011-1039-y.